Source: Annual Congress 2006 - Implications of progressive airway obstruction
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. V. Rasputina, Y. M. Mostovoy, N. S. Slepchenko (Vinnitsa, Ukraine). Undiagnosed and untreated rhythm disturbances and arterial hypertension in development of chronic obstructive lung disease exacerbation. Eur Respir J 2006; 28: Suppl. 50, 3651

Member's Comments

No comment yet.

Related content which might interest you: Beta-blockade therapy in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure in the presence and absence of pulmonary hypertension Source: Annual Congress 2010 - COPD: management Year: 2010 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2011; 39: 51-58 Year: 2012 Unrecognised ventricular dysfunction in COPD Source: Eur Respir J 2012; 39: 51-58 Year: 2012 Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 The respiratory circadian rhythm disturbances in the patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - COPD: from biomarker profiling to clinical assessment Year: 2009 Are severe asthma and chronic obstructive pulmonary disease the same disease? Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006 Rhinovirus-infection in chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 591s Year: 2002 Inflammation and depression in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 718s Year: 2007 Phenotypic characteristics of patients with arterial hypertension and chronic obstructive pulmonary disease Source: Annual Congress 2012 - COPD comorbidities I Year: 2012 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 Pulmonary hypertension and exercise capacity in patients with severe chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Sleep disorders in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020 Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease. Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018 Comorbidities in the course of chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Peculiarities of cardiac rhythm in stable chronic obstructive pulmonary disease Source: International Congress 2017 – Highlights on clinical problems in COPD Year: 2017 Pulmonary hypertension associated with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 656s Year: 2006 Arterial hypertension in patients with obstructive lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 417s Year: 2003 Periodontitis and chronic obstructive pulmonary disease Source: Annual Congress 2006 - COPD and inflammation Year: 2006 Mechanisms of ECG changes in chronic obstructive pulmonary disease Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016